Sikar doc, pharmacist suspended; new guidelines for syrup issued

Jaipur:  The health department on Thursday suspended a govt doctor and a pharmacist of Sikar district for allegedly prescribing a cough syrup containing dextromethorphan to children, a drug which cannot be prescribed to those under four years. This follows the deaths of two children who allegedly died in Sikar and Bharatpur districts after taking ‘Dextromethorphan HBr Syrup’.In its Thursday edition, TOI had in a report — ‘State govt failed to heed previous cough syrup warnings, say activists’ — highlighted the death of children allegedly after taking the syrup in Delhi in 2021, and how the state govt had failed to learn from the incident.

Acting on the news report, the health department on Thursday issued fresh guidelines for prescribing the cough syrup and suspended a doctor and a pharmacist for allegedly prescribing the medicine to children. The department’s director of public health, Dr Ravi Prakash Sharma, said action has been taken to suspend Dr Palak and pharmacist Pappu Soni for prescribing the syrup to a child at Hathideh PHC in Ajitgarh block of Sikar.Along with necessary action in the case, the department also issued an advisory on following protocol of providing medicines to patients only with prescriptions.It also advised patients against taking medicines without medical consultation, and called for complete compliance of doctors with the advisory.

The department also clarified that some children who had consumed the syrup had survived. A 30-year-old patient Monu Joshi, a resident of Kalsada, Bharatpur, had come to CHC on Sept 25, with cough, cold, and fever on Sept 25. The doctor had prescribed the syrup to him along with other medicines. When his three-year-old son Gagan caught cold and pneumonia, Joshi gave the syrup to the child without a doctor’s advice.The child’s condition worsened and he was taken to a doctor in Mahua, who referred him to JK Lon, Jaipur. His condition improved and he was discharged on Sept 27.

Related Posts

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

NEW DELHI—  Abbott, the global healthcare company, today announced the launch of XIENCE Skypoint in India. This is Abbott’s most advanced generation stent within the globally trusted XIENCE™ family of…

Top 30 pharma companies post 12% revenue growth in first nine months

Mumbai:  The aggregate financial performance of top 30 Indian pharmaceutical companies, with revenues of over Rs. 2,500 crore during 2024-25, remained under pressure during the first nine months of FY2025-26…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Abbott introduces its most advanced drug eluting stent XIENCE Skypoint™ in India

Top 30 pharma companies post 12% revenue growth in first nine months

Top 30 pharma companies post 12% revenue growth in first nine months

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

Ludhiana police seize 56 kg ganja; courier warehouse under scanner

AsterDMHealthcare-QCIL Merger mirrors Overwhelming Trust in Leadership

AsterDMHealthcare-QCIL Merger mirrors Overwhelming Trust in Leadership

DCGI asks drugmakers to stop GLP-1 obesity awareness ad campaigns

DCGI asks drugmakers to stop GLP-1 obesity awareness ad campaigns